Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss ...

Lilly’s CEO David Ricks downplayed the impact of the CVS decision to investors during the company’s earnings call. “We’re not surprised that this kind of thing was announced,” Ricks said.

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

Lilly’s results from an obesity pill study didn’t perform as well as Wall Street expected. It resulted in lower weight loss ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Eli Lilly & Co.’s shares saw the biggest one-day drop since 2008 after CVS Health Corp. announced a plan to drop its blockbuster weight-loss drug Zepbound from its preferred list, making rival ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.3% in the morning session after its key competitor in the ...

Yes. Lilly sells vials of Zepbound to consumers through its online sales portal, LillyDirect. The lowest dose of 2.5 milligrams starts at $349 for four single doses that will last four weeks.

CVS Health Corp. will administer Eli Lilly and Co.’s COVID-19 treatment in patients’ homes and in long-term care facilities through a program with the U.S. government’s Operation Warp Speed ...

CVS Health Corp said on Wednesday it would administer Eli Lilly & Co's experimental antibody treatment to COVID-19 patients in their homes and in long-term care facilities through a U.S ...

Eli Lilly will deliver the $812.5 million in doses through Jan. 31, 2021, with at least 350,000 to be delivered by the end of December, the drugmaker announced Wednesday.